M1048E01-180413

Assay Solutions Snibe - protocols - units

Conversion factor of MAGLUMITM parameters
C-Peptide 0.3 - 3.73 ng/mL (before meal) 0.01 - 20 ng/mL 1 week ȝO AFP(Prenatal
1.13 - 450 IU/mL 2 weeks ȝO
Parameter Default unit Conversion factor Parameter Default unit Conversion factor Screening)
The final risk should be
Insulin ȝ,8P/EHIRUHPHDO ȝ,8P/ 1 week ȝO Prenatal associated with prenatal 1.1 - 200 ng/mL 2 weeks ȝO
IUHHȕ+&*
Screening screening software
Estradiol pg/mL pg/mL × 3.67 = pmol/L T4 ng/mL ng/mL × 1.287 = nmol/L
Glyco Proinsulin 30 - 180 pg/mL (before meal) 2.0 - 5000 pg/mL 1 week ȝO PAPP-A 25 - 24000 mIU/L 2 weeks ȝO
PRG ng/mL nmol/L × 3.18 = ng/mL FT3 pg/mL pg/mL × 1.54 = pmol/L Metabolism IAA < 20 IU/mL 2 - 175 IU/mL 2 weeks ȝO free Estriol 0.13 - 40.00 ng/mL 2 weeks ȝO
Testosterone ng/mL ng/mL
L × 3.47 = nmol/L FT4 pg/mL pg/mL × 1.287 = pmol/L Anti-IA2 < 28 U/mL 2.5 - 280 U/mL 2 weeks ȝO hs-cTn I < 10 pg/mL (95th percentile),< 20 pg/mL (99th percentile) 1.0 - 2000 pg/mL 1 week ȝO

PAPP-A mIU/mL ȝJP/î mIU/mL D-Dimer ȝJ)(8/mL QJ)(8P/î ȝJ)(8/mL ICA < 28 U/mL 2.0 - 280 U/mL 2 weeks ȝO Lp-PLA2 < 250 ng/mL 1 - 1000 ng/mL 1 week ȝO

GAD 65 < 17 IU/mL 1 - 280 IU/mL 2 weeks ȝO Myoglobin < 60 ng/mL 0.2- 2000 ng/mL 4 weeks ȝO
AFP IU/mL IU/mL × 0.83 = ng/mL AFP(Prenatal The 99th percentile value were 103 ng/ml
IU/mL IU/mL × 0.83 = ng/mL
Screening) CRP Adult: < 0.7 mg/L 0.00013 - 100.00 mg/L 2 weeks ȝO
CEA ng/mL mIU/mL × 15 = ng/mL Aldosterone Lying: 30 - 160 pg/mL ,Standing: 70 - 300 pg/mL 5 - 2000 pg/mL 1 week ȝO
Inflammation
ng/mL ng/mL × 1.54 = nmol/L index/mL PCT Serum/Plasma: < 0.5 ng/mL,Whole blood: < 0.5 ng/mL 0.01 - 100 ng/mL 2 weeks ȝO Troponin I < 0.1 ng/mL 0.01 - 50 ng/mL 1 week ȝO
T3 HBsAg index/mL × 10 = IU/mL
Osteoporosis: 7 - 48 ng/mL, AⅠ Lying: 0.15 - 2.33 ng/mL/hr,Standing: 0.10 - 6.56 ng/mL/hr 0.1 - 24 ng/mL 1 week ȝO
FA ng/mL nmol/L × 2.265 = ng/mL
Healthy female:
Premenopausal: 6-43 ng/mL , AⅡ Lying: 25 - 60 pg/mL,Standing: 50 - 120 pg/mL 5 - 1000 pg/mL 1 week ȝO
Osteocalcin Postmenopausal: 8-46 ng/mL , 0.13 - 300 ng/mL 1 week ȝO 8SULJKWSRVWXUHȝ,8P/
All parameters are recommended to apply serum except the parameters below Health male: Cardiac Direct Renin
6XSLQHSRVWXUHȝ,8P/
ȝ,8P/ 1 week ȝO
18-30 years old: 15-65 ng/mL,
Bone 30-50 years old: 5-42 ng/mL, CK-MB < 5 ng/mL 0.625 - 500 ng/mL 2 weeks ȝO
Parameter Sample Type Parameter Sample Type Parameter Sample Type Parameter Sample Type 50-70 years old: 3-46 ng/mL
D-Dimer ȝJ)(8P/ ȝJ)(8P/ 1 week ȝO
Calcitonin < 18 pg/mL 2 - 5000 pg/mL 1 week ȝO
HIV Ag/Ab Combi Serum/Plasma ȕ0* Serum/Urine IgG (Urine) Urine ACTH Plasma H-FABP < 6 ng/mL 0.280 - 360 ng/mL 1 week ȝO

Serum/Urine Intact PTH 15 - 75 pg/mL 1.0- 5000 pg/mL 2 weeks ȝO

HTLV Ⅰ+Ⅱ Serum/Plasma Cortisol Direct Renin EDTA-Plasma AⅠ- A Ⅱ Plasma 1-3 years old: 234 ng/mL, 4-6 years old: 115 ng/mL,
25-OH Vitamin D 30 - 100 ng/mL 3 - 150 ng/mL 1 week ȝO 7-9 years old: 93 ng/mL, 10 years old: 71 ng/mL,
HIV Ag/Ab Combi Serum/Plasma Syphilis Serum/Plasma Chagas Serum/Plasma Aldosterone Serum/Urine 11 years old：92 ng/mL，12 years old: 94 ng/mL,
CSA 100 - 400 ng/mL 12.5 - 2000 ng/mL 1 week ȝO NT-proBNP 13 years old: 116 ng/mL, 14 years old: 65 ng/mL, 2.0 - 35000 pg/mL 1 week ȝO
PCT Serum/Plasma/Whole blood HIV p24 Serum/Plasma IgA (Urine) Urine FK 506 Whole blood 15 years old: 72 ng/mL, 16 years old: 83 ng/mL,
Drug
Digoxin 0.9 - 2 ng/mL 0.13 - 50 ng/mL 1 week ȝO 17 years old: 70 ng/mL, 18 years old: 52 ng/mL,
Monitoring
D-Dimer Plasma CSA Whole blood H-ALB Urine 18-44 years old: 96.5 ng/mL, 45-54 years old:123 ng/mL,
FK 506 3.0 - 39.4 ng/mL 0.1 - 100 ng/mL 1 week ȝO 55-64 years old: 225 ng/mL, 65-74 years old: 325 ng/mL,
※EDTA plasma tube is recommended; while Heparin plasma tube may interfere with the detection.
ȝO •\HDUVROGQJP/
Chagas < 1.0 index/mL 0.1 - 100 index/mL 2 weeks
HA < 100 ng/mL 5 - 2000 ng/mL 2 weeks ȝO
Parameter Basic Information HBsAg < 1 index/mL 0.01 - 10000.0 index/mL 1 week ȝO
PⅢPN-P < 30 ng/mL 5.0 - 2000 ng/mL 2 weeks ȝO
Anti-HCV < 20 AU/mL 0.01 - 1000.0 AU/mL 1 week ȝO Hepatic
Group Parameter Reference Range Measuring Range Calibration Sample CⅣ < 30 ng/mL 5.0 - 2000 ng/mL 2 weeks ȝO
Frequeny Volume Fibrosis
Anti-HBc < 100 index/mL 0.01 - 500.0 index/mL 1 week ȝO
Laminin < 50 ng/mL 2.0 - 1000 ng/mL 2 weeks ȝO
TSH ȝ,8P/ ȝ,8P/ 2 weeks ȝO Anti-HBs < 10 mIU/mL 0.01 - 1000.0 mIU/mL 1 week ȝO Cholylglycine ȝJP/ ȝJP/ 1 week ȝO
T3 0.69 - 2.15 ng/mL 0.06 - 10 ng/mL 1 week ȝO
TRAb < 1.5 IU/L 0.25 - 30 IU/L 2 weeks ȝO Anti-HBe < 100 index/mL 0.01 - 400.0 index/mL 1 week ȝO EBV EA IgG < 2 AU/mL 0.01 - 30 AU/mL 1 week ȝO
Infectious
T4 52 - 127 ng/mL 1.0 - 300 ng/mL 1 week ȝO
HBeAg < 15 index/mL 0.01 - 6000.0 index/mL 2 weeks EBV EA IgA < 3 AU/mL 0.01 - 30 AU/mL 1 week ȝO
ȝO
FT3 2.0 - 4.2 pg/mL 0.2 - 50 pg/mL 1 week ȝO
EBV VCA IgG < 2 AU/mL 0.01 - 50 AU/mL 1 week ȝO
Thyroid FT4 8.9 - 17.2 pg/mL 1.0 - 120 pg/mL 1 week ȝO Anti-HAV < 20 mIU/mL 3.50 - 100.0 mIU/mL 1 week ȝO EBV
EBV VCA IgA < 4 AU/mL 0.01 - 30 AU/mL 1 week ȝO
Rev T3 0.31 - 0.95 ng/mL 0.05 - 10 ng/mL 1 week ȝO HAV IgM < 2 AU/mL 0.01 - 20.000 AU/mL 4 weeks ȝO
Anti-TPO < 30 IU/mL 0.38 - 1000 IU/mL 1 week ȝO EBV VCA IgM < 3 AU/mL 0.01 - 30 AU/mL 4 weeks ȝO
HIV Ag/Ab Combi < 1 AU/mL 0.01 - 500 AU/mL 2 weeks ȝO
TG < 55 ng/mL 5 - 55 ng/mL 2 weeks ȝO EBV NA IgG < 2 AU/mL 0.01 - 50 AU/mL 1 week ȝO
TGA < 95 IU/mL 0.5 - 2800 IU/mL 2 weeks ȝO Syphilis < 1.0 mIU/mL 0.01 - 600 mIU/mL 2 weeks ȝO Vitamin B12 200 - 1100 pg/mL 12.5 - 2000 pg/mL 3 days ȝO
TMA < 32 IU/mL 0.15 - 1000 IU/mL 2 weeks ȝO
HTLV Ⅰ+Ⅱ < 1.0 index/mL 0.01 - 500 index/mL 2 weeks ȝO Anemia FA 5.21 - 20 ng/mL 0.375 - 24 ng/mL 3 days ȝO
Girls:
1 month: 2.4-16.8 ng/mL, 2 month: 1.6-9.7 month
AFP < 6.05 IU/mL 0.5 - 1000.0 IU/mL 4 weeks ȝO Ferritin Male: 25 - 350 ng/mL， Female: 13 - 232 ng/mL 2 - 3000 ng/mL 4 weeks ȝO
3 month: 0.1-3.1 ng/mL,
Boys: 1-7 days: male: 1.18 - 27.0 ng/mL, female: 2.4-24.0 ng/mL
CEA < 5.093 ng/mL 0.5 - 1000.0 ng/mL 4 weeks ȝO
1 month: 0.0-8.0 ng/mL, 2 month: 3.6-13.7 month 8-15 days: male: 0.69-17.3 ng/mL , female: 1.07-17.6 ng/mL
3 month: 1.7-4.0 ng/mL 0.1 - 20 ng/mL 2 weeks ȝO 1-3 years old: male: 0.43-2.4 ng/mL , female: 0.50-3.5 ng/mL
17-OH Progesterone Ferritin Male: 25 - 350 ng/mL， Female: 13 - 232 ng/mL 0.2 - 3000.0 ng/mL 4 weeks ȝO
Children: 3-14 years old: 0.1-1.7 ng/mL 4-6 years old: male: 0.09-2.5 ng/mL , female: 0.10-2.2 ng/mL,
Adult female: CA 125 < 35 U/mL 0.5 - 1200.0 U/mL 1 week ȝO 7-8 years old: male: 0.15-3.2 ng/mL, female: 0.16-5.4 ng/mL
Follicular phase: 0.1-0.8 ng/mL, Luteal phase: 0.6-2.3 ng/mL 9-10 years old : male: 0.09-1.95 ng/mL，female: 0.08-3.1 ng/mL
Ovulatory period: 0.3-1.4 ng/mL, Post ACTH: < 3.2 ng/mL CA 15-3 < 25 U/mL 1.600 - 1000.0 U/mL 2 weeks ȝO 11 years old: male: 0.08-4.7 ng/mL，female: 0.12-6.9 ng/mL
Late pregnancy: 2.0-12 ng/mL, Menopause: 0.13-0.51 ng/mL GH 0.050 - 50.00 ng/mL 4 weeks ȝO
12 years old: male: 0.12-8.9 ng/mL，female: 0.14-11.2 ng/mL
Normal male: 0.5-2.1 ng/mL CA 19-9 < 37 U/mL 1.000 - 1000.0 U/mL 2 weeks ȝO 13 years old: male: 0.10-7.9 ng/mL，female: 0.21-17.8 ng/mL
Males:<2 mIU/mL, Non-pregnant females:< 10 mIU/mL CA 50 < 25 U/mL 0.5 - 500.0 U/mL 2 weeks ȝO 14 years old: male: 0.09-7.1 ng/mL，female: 0.14- 9.9 ng/mL
Normal pregnant females: 15 years old: male: 0.10-7.8 ng/mL， female: 0.24-10.0 ng/mL
3-7 days: 5-50 mIU/mL, 1-2 weeks: 50-500 mIU/mL, CA 242 < 20 U/mL 0.500 - 200.0 U/mL 1 week ȝO 16 years old: male: 0.08-11.4 ng/mL， female: 0.26-11.7 ng/mL
+&*ȕ+&* 2-3 weeks: 100-5000 mIU/mL, 3-4 weeks: 500-10000 mIU/mL, 0.3 - 5000 mIU/mL 4 weeks ȝO 17 years old: male: 0.22-12.2 ng/mL， female: 0.30-10.8 ng/mL
4-5 weeks： 1000-50000 mIU/mL， CA 72-4 < 6 U/mL 2.0 - 500.0 U/mL 2 weeks ȝO 18-19 years old: male: 0.97-4.7 ng/mL， female: 0.24-4.3 ng/mL
6-8 weeks： 15000-200000 mIU/mL, 1-5 years old: 45-305 ng/mL , 6-10 years old: 50-410 ng/mL,
Tumor CYFRA 21-1 < 7 ng/mL 1.0 - 1000.0 ng/mL 1 week ȝO
2-3 months: 10000-100000 mIU/mL IGF-Ⅰ 11-15 years old: 80-900 ng/mL , 16-20 years old: 75-850 ng/mL, 5.0 - 2000.0 ng/mL 1 week ȝO
Markers
SCCA < 2.5 ng/mL 0.1 - 100.00 ng/mL 4 weeks ȝO >20 years old: 60-350 ng/mL , 16-20 years old: 75-850 ng/mL
Healthy males: 0.834 - 13.25 ng/mL Others
Healthy females: 20-24 years old: 1.135-11.46 ng/mL S-100 < 0.2 ng/mL 0.020 - 50.00 ng/mL 2 weeks ȝO Serum:
25-29 years old: 0.775-9.752 ng/mL
Time: 8:30-9:30, 72.6-322.8 ng/mL,
AMH 30-34 years old: 0.334-7.834 ng/mL 0.02 - 25 ng/mL 1 week ȝO PAP < 2 ng/mL 0.02 - 100 ng/mL 2 weeks ȝO 16:30-[Link] 32.4-150.0 ng/mL
35-39 years old: 0.133-6.657 ng/mL Cortisol 2.5 - 600.0 ng/mL 2 weeks ȝO
Urine：
40-44 years old: 0.027-5.267 ng/mL
Total PSA Male: < 4 ng/mL， Female: < 0.5 ng/mL 0.010 - 400.0 ng/mL 4 weeks ȝO ȝJKRXU0DQXDOFDOFXODWLRQIRUXULQDU\IUHHFRUWLVRO
45-50 years old: 0.02-2.824 ng/mL
cortisol excretion over 24-hour (cortisol concentration/24 h):
Males: 0.23-1.50 ng/mL f-PSA Male: < 1.5 ng/mL，Female: < 0.1 ng/mL 0.05 - 60.00 ng/mL 4 weeks ȝO Multiply the analyzer result by the volume of the 24-hour urine.
Non-pregnant females:
PG Ⅰ 70 - 240 ng/mL 1.000 - 250.00 ng/mL 1 week ȝO Time: 8:00-10:00, 6-48 pg/mL, 16:00, 3-30 pg/mL
Follicular phase: 0.36-1.21 ng/mL ACTH 0.5 - 2000.0 pg/mL 1 week ȝO
Luteal phase: 2.12-26.44 ng/mL 24:00,<20 pg/mL
PG Ⅱ < 13 ng/mL 1.000 - 100.00 ng/mL 1 week ȝO
PRG Ovulatory phase: 0.39-22.87 ng/mL 0.1 - 80 ng/mL 2 weeks ȝO \HDUVROGPDOHȝJG/IHPDOHȝJG/
Fertility Postmenopause: 0-0.89 ng/mL [Link] IgG < 30 EIU 2.0 - 200.0 EIU 1 week ȝO \HDUVROGPDOHȝJG/IHPDOHȝJG/
Pregnant females: \HDUVROGPDOHȝJG/，IHPDOHȝJG/
0-12 weeks: 1.17-49.9 ng/mL, 13-28 weeks: 15.4-68.9 ng/mL NSE < 6 ng/mL 0.5 - 500.0 ng/mL 4 weeks ȝO ȝJG/ 1 week ȝO
DHEA-S \HDUVROGPDOHȝJG/，IHPDOHȝJG/
29-40 weeks: 59.8-780 ng/mL TPA-snibe < 75 U/L 12.5 - 6000 U/L 2 week ȝO \HDUVROGPDOHȝJG/，IHPDOHȝJG/
Males: < 87 pg/mL \HDUVROGPDOHȝJG/，IHPDOHȝJG/
Gastrin-17 2 - 10 pmol/L 1.0- 500.0 pmol/L 1 weeks ȝO
Females: !\HDUVROGPDOHȝJG/，IHPDOHȝJG/
Follicular phase: 15-112 pg/mL Toxo IgG < 2 IU/mL 0.01 - 30.00 IU/mL 4 weeks ȝO
Estradiol Luteal phase: 48-172 pg/mL 5 - 6000 pg/mL 2 weeks ȝO
Neg: < 2 AU/mL，Grey Zone: 2 - 2.6 AU/mL
Hormonal contraceptives: 15-95 pg/mL Toxo IgM 0.01 - 30.00 AU/mL 4 weeks ȝO
Postmenopause: 10-66 pg/mL Pos: > 2.6 AU/mL
Prevlulatory phase: 136-251 pg/mL Rubella IgG < 2 IU/mL 0.25 - 30.00 IU/mL 4 weeks ȝO
0DOHVȝ,8P/ Rubella IgM Neg: < 2 AU/mL，Grey Zone: 2 - 3 AU/mL 0.01 - 30.00 AU/mL 1 week ȝO
Female: Pos: > 3 AU/mL
PRL ȝ,8P/ 4 weeks ȝO TORCH
1RUPDOȝ,8P/
CMV IgG < 2 AU/mL 0.01 - 30.00 AU/mL 1 week ȝO
3RVWPHQRSDXVDOȝ,8P/
CMV IgM Neg: < 2 AU/mL， Grey Zone: 2 - 4.2 AU/mL 0.01 - 30.00 AU/mL 4 weeks ȝO
Males: 1.1-25 mIU/mL Pos: > 4.2 AU/mL
Females:
Follicular phase: 1.2-12.5 mIU/mL HSV-1/2 IgG < 2 AU/mL 0.25 - 60.00 AU/mL 4 weeks ȝO
LH 0.1 - 250 mIU/mL 4 weeks ȝO
Luteal phase: 0.4-19 mIU/mL
Ovulatory phase: 12-82 mIU/mL HSV-1/2 IgM Neg: < 2 AU/mL， Grey Zone: 2 - 4 AU/mL 0.01 - 30.00 AU/mL 4 weeks ȝO
Postmenopause: 14-48 mIU/mL 3RV•$8P/
HSV-2 IgG < 2 AU/mL 0.01 - 30.00 AU/mL 4 weeks ȝO
Males: 1.5-11.8 mIU/mL
Females: IgE 1 - 190 IU/mL 1 - 3200 IU/mL 4 weeks ȝO
FSH Follicular phase: 3.2-15 mIU/mL 0.1 - 400 mIU/mL 4 weeks ȝO
Luteal phase: 1.3-11 mIU/mL IgM ȝJP/ ȝJP/ 4 weeks ȝO
Ovulatory phase: 7.5-20 mIU/mL
Postmenopause: 36-138 mIU/mL IgG (Serum) 5 - 17 mg/mL ȝJP/ 1 week ȝO
Immunoglobulin
free-Testosterone Male: 15 - 50 pg/mL, Female: < 4.2 pg/mL 0.5 - 150 pg/mL 1 week ȝO IgA (Serum) ȝJP/ ȝJP/ 1 week ȝO
Testosterone Male: 2.2 - 10.5 ng/mL, Female: < 1.0 ng/mL 0.13 - 17 ng/mL 2 weeks ȝO
IgA (Urine) ȝJP/ ȝJP/ 4 weeks ȝO
Kidney ȕ0* 6HUXPȝJP/8ULQHȝJP/ ȝJP/ 1 week ȝO
Function ȝJP/ ȝO IgG (Urine) ȝJP/ ȝJP/ 1 week ȝO To Be The Pioneer In Global Diagnosis Field
H-ALB ȝJP/ 1 week